Plenti-CMV-MCS-RFP-SV-puro Citations (4)

Originally described in: Behzad Gerami-Naini lab plasmids
Unpublished

Articles Citing Plenti-CMV-MCS-RFP-SV-puro

Articles
High-Resolution Imaging of Tumor Spheroids and Organoids Enabled by Expansion Microscopy. Edwards SJ, Carannante V, Kuhnigk K, Ring H, Tararuk T, Hallbook F, Blom H, Onfelt B, Brismar H. Front Mol Biosci. 2020 Sep 24;7:208. doi: 10.3389/fmolb.2020.00208. eCollection 2020. PubMed
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity. Casares L, Moreno R, Ali KX, Higgins M, Dayalan Naidu S, Neill G, Cassin L, Kiib AE, Svenningsen EB, Minassi A, Honda T, Poulsen TB, Wiel C, Sayin VI, Dinkova-Kostova AT, Olagnier D, de la Vega L. Redox Biol. 2022 May;51:102291. doi: 10.1016/j.redox.2022.102291. Epub 2022 Mar 17. PubMed
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner. Alewine G, Knight J, Ghantae A, Mamrega C, Attiah B, Coover RA, Fahrenholtz CD. J Pers Med. 2022 Jun 30;12(7):1080. doi: 10.3390/jpm12071080. PubMed
Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Plexiform Neurofibroma Cells at Doses That Do Not Affect Patient-Matched Schwann Cells. Attiah B, Alewine G, Easter MK, Coover RA, Fahrenholtz CD. Pharmaceutics. 2024 Mar 7;16(3):371. doi: 10.3390/pharmaceutics16030371. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.